This was the stock's second consecutive day of losses.

Shares of Elevance Health, Inc. (NYSE:ELV – Get Free Report) have been given a consensus rating of “Moderate Buy” by the ...

Hotchkis & Wiley, an investment management company, released its “Hotchkis & Wiley Large Cap Fundamental Value Fund” fourth ...

Elevance Health (ELV) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price ...

Equities researchers at Wolfe Research issued their FY2029 earnings per share (EPS) estimates for Elevance Health in a note issued to investors on Monday, March 31st. Wolfe Research analyst J. Lake ...

River Road Asset Management, an investment management company released its “River Road Large Cap Value Select Fund” Q4 2024 ...

Buying $100 In ELV: If an investor had bought $100 of ELV stock 15 years ago, it would be worth $667.52 today based on a ...

For the first time in 15 years, employment across the major health insurance companies fell last year, according to a Modern ...

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

Elevance Health trades at $423.06 per share and has stayed right on track with the overall market, losing 14% over the last ...

Bernstein raised the firm’s price target on Elevance Health (ELV) to $585 from $511 and keeps an Outperform rating on the shares. The firm sees ...

In its fourth quarter 2024 investor letter, Hotchkis & Wiley Large Cap Fundamental Value Fund emphasized stocks such as Elevance Health, Inc. (NYSE:ELV). Elevance Health, Inc. (NYSE:ELV ...